Article Sidebar
Views pdf: 93
STUDYING LIVER FIBROSCAN ULTRASOUND IMAGING CHARACTERISTICS IN PATIENTS WITH TYPE 2 DIABETES TYPE 2 DIABETES
Main Article Content
Abstract
Objective: To describe the characteristics of liver fibroscan ultrasound images in patients with type 2 diabetes. Subjects and methods: Cross-sectional and prospective description of 142 type 2 diabetes patients undergoing Fibroscan ultrasound at Military Hospital 103 from April 2023 to February 2024. Results: The average fatty liver index on Fibroscan was 250.2 ± 63.8 dB/m. Most patients have grade S3 fatty liver on Fibroscan (28.9%). There is no difference between the degree of fatty liver on Fibroscan and the duration of type 2 diabetes. The average liver fibrosis index on Fibroscan is 6.16 ± 3.1 kPa. Most patients have grade F1 fibrosis on Fibroscan (14.1%). There was no difference in the average liver fibrosis index over time. Conclusion: The average fatty liver index on Fibroscan was 250.2 ± 63.8 dB/m. Most patients have grade S3 fatty liver on Fibroscan (28.9%). The average liver fibrosis index on Fibroscan was 6.16 ± 3.1 kPa. Most patients have grade F1 fibrosis on Fibroscan (14.1%). Duration of type 2 diabetes does not affect the degree of fatty liver and fibrosis on Fibroscan.
Article Details
Keywords
: Fatty liver, Liver fibrosis, Fibroscan.
References
2. Wong Vincent Wai‐Sun, Vergniol Julien, Wong Grace Lai‐Hung et al. (2010), "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease", Hepatology, 51(2), pp. 454-462.
3. Sasso Magali, Beaugrand Michel, De Ledinghen Victor et al. (2010), "Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes", Ultrasound in medicine & biology, 36(11), pp. 1825-1835.
4. Kwok Raymond, Choi Kai Chow, Wong Grace Lai-Hung et al. "Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study", Gut. 2015;pp. 2015-309265.
5. Trần Thị Khánh Tường, Phạm Quang Thiên Phú. "Mối tương quan giữa mức độ nhiễm mỡ gan và xơ hóa gan ở bệnh nhân đái tháo đường típ 2 bị bệnh gan nhiễm mỡ không do rượu", Tạp chí y học Việt Nam. 2020; 488(1), pp. 21 - 25.
6. Asero C., Giandalia A., Cacciola I. et al. (2023), "High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease", J Clin Med, 12(8).
7. Lomonaco Romina, Godinez Leiva Eddison, Bril Fernando et al. (2021), "Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening", Diabetes Care, 44(2), pp. 399-406.